Fig. 2From: Ustekinumab trough levels predicting laboratory and endoscopic remission in patients with Crohn’s diseaseComparison of clinical markers between patients with endoscopic remission (score 0 and 1) and patients with no endoscopic remission (score 2, 3 and 4). The dashed line in AUA indicates the cutoff value to be judged as positive (0.27) [26]. UST, ustekinumab; AUA, anti-ustekinumab antibodies; CDAI, Crohn’s disease activity indexBack to article page